DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
02 2Granules India Limited
03 1ANDAS 5 HOLDING
04 1Actavis Inc
05 1Aurobindo Pharma Limited
06 1Micro Labs Limited
07 1Takeda Pharmaceutical
08 1Upsher-Smith Laboratories
09 1Xiromed
10 1Zydus Pharmaceuticals
11 1i3 Pharmaceuticals
01 1Immediate Release Tablet
02 11TABLET;ORAL
01 1ROW, US
02 11RX
01 10RAMELTEON
02 1ROZEREM
03 1Blank
01 1India
02 11USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : RAMELTEON
Dosage Form : TABLET;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2013-07-26
Application Number : 91693
Regulatory Info : RX
Registration Country : USA
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : RX
Registration Country : USA
Brand Name : RAMELTEON
Dosage Form : TABLET;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2020-08-21
Application Number : 213186
Regulatory Info : RX
Registration Country : USA
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : ROW, US
Registration Country : India
Brand Name :
Dosage Form : Immediate Release Tablet
Dosage Strength : 8MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : ROW, US
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : RAMELTEON
Dosage Form : TABLET;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2015-08-19
Application Number : 91610
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RAMELTEON
Dosage Form : TABLET;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2023-07-10
Application Number : 215972
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RAMELTEON
Dosage Form : TABLET;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2020-04-10
Application Number : 212650
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RAMELTEON
Dosage Form : TABLET;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2023-02-09
Application Number : 215243
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROZEREM
Dosage Form : TABLET;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2005-07-22
Application Number : 21782
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RAMELTEON
Dosage Form : TABLET;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2020-10-26
Application Number : 213815
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RAMELTEON
Dosage Form : TABLET;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2022-11-25
Application Number : 216209
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RAMELTEON
Dosage Form : TABLET;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2019-07-22
Application Number : 211567
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RAMELTEON
Dosage Form : TABLET;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2022-08-24
Application Number : 215435
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?